Evoke Pharma (EVOK) Tops Q4 EPS by 20c

Evoke Pharma (NASDAQ: EVOK) reported Q4 EPS of ($0.48), $0.20 better than the analyst estimate of ($0.68).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Advicenne Reports First Half Financial Results as of June 30, 2026, and Updates on Its Activities
• Investec Double Upgrades Supreme Industries (SI:IN) to Buy